Guido Carpino

31PUBLICATIONS
117CO-AUTHORS
Cancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisOphthalmologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Apr 28, 2026
MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growth.

|Jan 19, 2026
RETRACTED: Mancinelli et al. The Effects of Taurocholic Acid on Biliary Damage and Liver Fibrosis Are Mediated by Calcitonin-Gene-Related Peptide Signaling. Cells 2022, 11, 1591.

Romina Mancinelli, Ludovica Ceci, Lindsey Kennedy

|Dec 10, 2025
Cholangiocarcinoma 2026: status quo, unmet needs and priorities.

Jesus M Banales, Pedro M Rodrigues, Silvia Affò

|Aug 05, 2025
Role of CNNM4 in the progression of cholangiocarcinoma: implications for ferroptosis and therapeutic potential.

Maria Mercado-Gómez, Naroa Goikoetxea-Usandizaga, Alvaro Eguileor Giné

|Jun 19, 2024
Oleuropein, a Component of Extra Virgin Olive Oil, Improves Liver Steatosis and Lobular Inflammation by Lipopolysaccharides-TLR4 Axis Downregulation.

Leonardo Schirone, Diletta Overi, Guido Carpino

|Mar 13, 2024
Cholangiocarcinoma Malignant Traits Are Promoted by Schwann Cells through TGFβ Signaling in a Model of Perineural Invasion.

Valerio de Franchis, Simonetta Petrungaro, Elisa Pizzichini

Pageof 6

Frequent Collaborators

15 joint publications

Diletta Overi

6 joint publications

Jesper B Andersen

6 joint publications

Rocio I R Macias

6 joint publications

Gianfranco Alpini